Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,409 results that match your search.22,409 results
  • The Law no 255 on the protection of new plant varieties entered in force on April 1 1999. This law provided for a system of protection of new plant varieties based on variety patents and it repealed the provisions on plant varieties enclosed in the Law no 64/1991 on patents of inventions.
  • As investment into Latin America increases, protecting famous trade marks becomes more important. Tony Ferguson compares the protection available in Argentina, Uruguay, Paraguay, Brazil and Chile
  • South Africa A L 1 (2) Spoor & Fisher Pretoria ? ? 2 (1) Adams & Adams Pretoria ? ? 3 (4) DM Kisch Johannesburg ? ? 4 (3) John & Kernick/Bowman Gilfillan Halfway House ? ? 5 (-) Hahn & Hahn Pretoria ? ?
  • Pre-launch patent searches can be costly and time-consuming. Andrew Inglis and Michael Molineaux examine whether they are really necessary in the UK, and compare the situation with other jurisdictions
  • Canada A L 1 (1) Smart & Biggar/Fetherstonhaugh & Co Ottawa ? ? 2 (2) Gowling Lafleur Henderson Ottawa ? ? 3 (5) Ridout & Maybee Toronto ? ? 4 (9) Blake Cassels & Graydon Toronto ? ? 5 (4) Swabey Ogilvy Renault/Ogilvy Renault Montreal ? ? 6 (7) Bereskin & Parr Toronto ? ? 7 (-) MBM & Co Ottawa ? ? 8 (-) MacRae & Co Ottawa ? ? 9 (8) Deeth Williams Wall Toronto ? ? 10 (-) Ade & Company Winnipeg ? ?
  • The Colombian Patent Office denied to grant a patent on an application filed by Pfizer Inc directed to a product known as "Viagra" , whose chemical name is pyrazolepyrimidone. The reason for this decision was that the application was trying to protect a new use of a known product. About the same time, the Peruvian Patent Office granted a patent to a corresponding patent application for the same subject matter.
  • A string of high-profile cases has raised the question of where the boundaries of trade mark protection should be drawn. In the first article in a series, a team of correspondents compare trade mark registrability in eight countries from China to Chile
  • Politicians and regulators are responding to competition in the pharmaceutical industry by threatening patent rights. The consequence will be all out war between branded companies and generics. Tabitha Parker reports from the front line
  • John A Tessensohn and Shusaku Yamamoto explain the evolution of a trade mark dispute over the Starbucks logo, and examine the usefulness of Japan's Unfair Competition Prevention Law
  • With the sequencing of the human genome, the question of patenting genes has become front page news. To shed some light on the controversial topic, MIP assembled seven biotech specialists at Taylor Joynson Garrett's offices in London, with telephone and video-links to the US. The wide-ranging debate covered utility, ESTs, examination standards, the role of patents and ethical objections. Chuck Ludlam begins the discussion